{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:31:27Z","timestamp":1760549487661},"reference-count":24,"publisher":"Elsevier BV","issue":"15","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.vaccine.2013.12.068","type":"journal-article","created":{"date-parts":[[2014,2,9]],"date-time":"2014-02-09T14:45:19Z","timestamp":1391957119000},"page":"1754-1760","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes"],"prefix":"10.1016","volume":"32","author":[{"given":"R.T.","family":"Ranallo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Baqar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.A.","family":"Lugo-Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Boren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Barnoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.12.068_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0264-410X(95)80006-Y","article-title":"Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates","volume":"13","author":"Baqar","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0010","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.1016\/j.vaccine.2011.04.115","article-title":"Shigella sonnei vaccine candidates WRSs2 and WRSs3 are as immunogenic as WRSS1, a clinically tested vaccine candidate, in a primate model of infection","volume":"29","author":"Barnoy","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0015","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.vaccine.2009.11.001","article-title":"Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity","volume":"28","author":"Barnoy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0020","first-page":"88","article-title":"Safety and colonization of two novel VirG(IcsA)-based live Shigella sonnei vaccine strains in rhesus macaques (Macaca mulatta)","volume":"58","author":"Collins","year":"2008","journal-title":"Comp Med"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0025","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1128\/IAI.67.7.3437-3443.1999","article-title":"Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602","volume":"67","author":"Coster","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0030","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.4049\/jimmunol.168.10.5240","article-title":"Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium","volume":"168","author":"D\u2019Hauteville","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/164.3.533","article-title":"Effect of prior infection with virulent Shigella flexneri 2a on the resistance of monkeys to subsequent infection with Shigella sonnei","volume":"164","author":"Formal","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0040","first-page":"205","article-title":"Oral shigella vaccines","volume":"146","author":"Hale","year":"1989","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0045","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1016\/j.vaccine.2005.07.023","article-title":"Establishment of a non-human primate Campylobacter disease model for the pre-clinical evaluation of Campylobacter vaccine formulations","volume":"24","author":"Islam","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0050","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/IAI.74.1.790-793.2006","article-title":"New World monkey Aotus nancymae as a model for Campylobacter jejuni infection and immunity","volume":"74","author":"Jones","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0055","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/IAI.70.4.2016-2021.2002","article-title":"Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults","volume":"70","author":"Kotloff","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0060","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0065","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0070","first-page":"109","article-title":"Live oral Shigella vaccine: vaccination schedule and the effect of booster dose","volume":"21","author":"Mel","year":"1974","journal-title":"Acta Microbiol Acad Sci Hung"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/IAI.53.1.57-63.1986","article-title":"Serum immune response to Shigella protein antigens in rhesus monkeys and humans infected with Shigella spp","volume":"53","author":"Oaks","year":"1986","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0080","doi-asserted-by":"crossref","first-page":"8027","DOI":"10.1128\/IAI.73.12.8027-8032.2005","article-title":"Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers","volume":"73","author":"Orr","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0085","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/IAI.69.3.1351-1357.2001","article-title":"Safety and immunogenicity of improved Shigella O-specific polysaccharide-protein conjugate vaccines in adults in Israel","volume":"69","author":"Passwell","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1574-695X.2012.01000.x","article-title":"Shigella flexneri O-antigens revisited: final elucidation of the O-acetylation profiles and a survey of the O-antigen structure diversity","volume":"66","author":"Perepelov","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0095","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1574-695X.2006.00118.x","article-title":"Developing live Shigella vaccines using lambda Red recombineering","volume":"47","author":"Ranallo","year":"2006","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0100","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1016\/j.vaccine.2012.05.003","article-title":"Two live attenuated Shigella flexneri 2a strains WRSf2G12 and WRSf2G15: a new combination of gene deletions for 2nd generation live attenuated vaccine candidates","volume":"30","author":"Ranallo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/IAI.00533-09","article-title":"Virulence, inflammatory potential, and adaptive immunity induced by Shigella flexneri msbB mutants","volume":"78","author":"Ranallo","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0110","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/clinids\/15.2.346","article-title":"Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides","volume":"15","author":"Robbins","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0115","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1128\/JCM.41.1.110-117.2003","article-title":"Phenotypic and genotypic characterization of provisional serotype Shigella flexneri 1c and clonal relationships with 1a and 1b strains isolated in Bangladesh","volume":"41","author":"Talukder","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.12.068_bib0120","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1099\/jmm.0.46999-0","article-title":"A novel serovar of Shigella dysenteriae from patients with diarrhoea in Bangladesh","volume":"56","author":"Talukder","year":"2007","journal-title":"J Med Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T06:42:22Z","timestamp":1597473742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":24,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0264410X14000711"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.068","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral administration of live Shigella vaccine candidates in rhesus monkeys show no evidence of competition for colonization and immunogenicity between different serotypes","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.12.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}